Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -73.87M
March 31, 2026 -51.66M
December 31, 2025 -105.76M
September 30, 2025 -68.81M
June 30, 2025 -58.36M
March 31, 2025 -41.99M
December 31, 2024 -57.78M
September 30, 2024 -135.36M
June 30, 2024 -140.68M
March 31, 2024 -143.16M
December 31, 2023 -156.20M
September 30, 2023 -144.99M
Date Value
June 30, 2023 -129.33M
March 31, 2023 -168.39M
December 31, 2022 -130.81M
September 30, 2022 -129.75M
June 30, 2022 -151.54M
March 31, 2022 -130.56M
December 31, 2021 -148.16M
September 30, 2021 -112.60M
June 30, 2021 -97.82M
March 31, 2021 -67.90M
December 31, 2020 -53.20M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Astrana Health, Inc. 107.87M
Starling Oncology, Inc. 0.328M
Nakamoto, Inc. -47.27M
American Oncology Network, Inc. --
Tenet Healthcare Corp. 4.015B